Abstract
For the maintenance therapy of breast cancer, drugs which act as antagonists/partial agonists of hormone receptors against the breast tissue are used in the conventional clinical practices. However, during the course of treatment the patients may encounter systems related complications. Drugs like tamoxifen, which block the action of estrogens at its receptors in mammary gland; and the recently designed antiestrogens and selective estrogen receptor modulators (SERM) like raloxifene, toremifene and the progesterone antagonist mifepristone (RU-486) are used in the treatment for estrogen and/or progesterone receptor positive breast tumors. These drugs show, however, both acute and long-term toxicity like endometrial hyperplasia and cancer, menopausal symptoms, edema, thromboembolic events like pulmonary embolism and so on. Using molecular docking method, we studied the binding of these drugs at an array of receptors present within the physiological system. In addition, the molecular basis of the antiglucocorticoid and antiandrogenic side effects of mifepristone have also been studied. Our results show weak to moderate binding of these drugs at various receptors of the body. This may explain the toxicity and pathophysiological shif...Continue Reading
References
Jan 1, 1992·Cancer Chemotherapy and Pharmacology·D de VosR J Briggs
Mar 15, 1996·American Journal of Epidemiology·I RomieuR Romero-Jaime
Oct 28, 1998·Journal of the National Cancer Institute·R M O'ReganV C Jordan
Mar 6, 1999·Breast Cancer Research and Treatment·C K Osborne
Jun 22, 1999·JAMA : the Journal of the American Medical Association·S R CummingsV C Jordan
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Feb 23, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·N N Sarkar
Mar 19, 2002·The Journal of Steroid Biochemistry and Molecular Biology·G ShyamalaS Nandi
Jul 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·H Kim CreweElizabeth M J Gillam
Nov 3, 2004·Nature Reviews. Drug Discovery·Douglas B KitchenJürgen Bajorath
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leena VehmanenTiina Saarto
May 10, 2006·PLoS Medicine·Andrew C AhnRussell S Phillips
Aug 22, 2007·IET Systems Biology·O Wolkenhauer
Aug 31, 2007·Nature Clinical Practice. Oncology·Susana BanerjeeLesley-Ann Martin
Sep 25, 2007·Bio Systems·Abhik Mukherjee, Durjoy Majumder
Oct 3, 2007·IET Systems Biology·D Majumder, A Mukherjee
Citations
Sep 16, 2011·Advances and Applications in Bioinformatics and Chemistry : AABC·Tarique N HasanP Sivashanmugham
Apr 6, 2016·Advances in Bioinformatics·Sayan MukherjeeDurjoy Majumder
Oct 22, 2010·Environmental Toxicology and Chemistry·Malin C CelanderJames R Wheeler
Nov 27, 2010·The Analyst·Durjoy Majumder, Abhik Mukherjee
Oct 27, 2018·Chemistry Central Journal·Deepika SharmaBalasubramanian Narasimhan